Description

CJC-1295 Without DAC 10mg + Ipamorelin 10mg Blend

Dual-Peptide Research Blend | 20mg Total Peptide Material

The CJC-1295 Without DAC 10mg + Ipamorelin 10mg Blend combines two distinct synthetic peptide research compounds in one formulation. The stated blend contains 10mg of CJC-1295 Without DAC and 10mg of Ipamorelin, giving a total of 20mg peptide material.

CJC-1295 Without DAC is a synthetic peptide related to the GHRH research area. PubChem reports its molecular formula as C₁₅₂H₂₅₂N₄₄O₄₂ and molecular weight as approximately 3367.9 g/mol.

Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂. PubChem reports a molecular formula of C₃₈H₄₉N₉O₅ and molecular weight of approximately 711.9 g/mol.

Because the two compounds have different molecular structures, researchers should identify and characterize them separately.

CJC-1295 Without DAC + Ipamorelin Research Profile

First, CJC-1295 Without DAC provides a defined peptide structure for research involving peptide chemistry, molecular characterization, and analytical testing. PubChem maintains a separate chemical record for the DAC-free form.

Next, Ipamorelin provides a distinct pentapeptide component associated with ghrelin-receptor research. Researchers can evaluate its sequence, identity, purity, molecular mass, and stability using suitable laboratory methods.

Therefore, this product should be documented as a two-component peptide blend, rather than as one chemical compound.

CJC-1295 Without DAC 10mg + Ipamorelin 10mg Composition

The quantities above reflect the product designation. However, the exact salt form, purity, formulation, and batch characteristics should be confirmed against the product label and batch-specific documentation.

CJC-1295 Without DAC Research Profile

CJC-1295 Without DAC is a defined synthetic peptide recorded separately from the DAC-modified form. PubChem reports the molecular formula C₁₅₂H₂₅₂N₄₄O₄₂ and molecular weight 3367.9 g/mol.

Researchers may examine CJC-1295 Without DAC for:

• Peptide identification
• Molecular characterization
• Purity and assay
• Sequence-related analysis
• Stability studies
• Analytical method development
• Comparative peptide research

Ipamorelin Research Profile

Ipamorelin is a defined pentapeptide. Its documented sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH₂, and PubChem lists it as a ghrelin mimetic associated with growth-hormone secretagogue activity.

Researchers may evaluate Ipamorelin for:

• Peptide sequence characterization
• Molecular identification
• Receptor-related research
• Purity analysis
• Stability studies
• Analytical characterization
• Comparative peptide research

Research Applications

Researchers may investigate this blend in controlled laboratory studies involving:

• Peptide chemistry
• Receptor biology
• GHRH-related research
• Ghrelin-receptor research
• Molecular characterization
• Analytical chemistry
• Purity and assay testing
• Peptide stability
• Formulation research
• Comparative peptide analysis

In addition, laboratories can examine each component independently before evaluating the complete formulation.

Key Characteristics

Dual-Peptide Formulation

The product combines CJC-1295 Without DAC and Ipamorelin in one research preparation.

Defined Component Quantities

The stated formulation contains 10mg of each peptide, providing 20mg total peptide material.

Distinct Molecular Identities

Each component has its own molecular structure and analytical characteristics. Consequently, laboratories should use appropriate methods for individual component identification.

Analytical Research Utility

Researchers may examine the blend for identity, purity, molecular mass, concentration, stability, and degradation characteristics.

Product Specifications

Product Name: CJC-1295 Without DAC 10mg + Ipamorelin 10mg Blend
CJC-1295 Without DAC: 10mg
Ipamorelin: 10mg
Total Peptide Material: 20mg
Product Type: Dual-peptide research blend
CJC-1295 Without DAC Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
CJC-1295 Without DAC Molecular Weight: 3367.9 g/mol
Ipamorelin Molecular Formula: C₃₈H₄₉N₉O₅
Ipamorelin Molecular Weight: 711.9 g/mol
Intended Application: Laboratory and analytical research

Quality & Documentation

Research-material documentation may include:

• Individual peptide identity
• Sequence information
• Component quantities
• Purity or assay
• Batch or lot number
• Certificate of Analysis (COA)
• Analytical testing
• Stability information
• Product specifications

Furthermore, researchers should compare the supplied material with the applicable batch-specific documentation.

Analytical Characterization

Because the formulation contains two different peptides, researchers can evaluate each component separately.

Depending on the laboratory method, testing may include:

• Identity confirmation
• Purity analysis
• Molecular-mass determination
• Concentration assessment
• Stability testing
• Degradation analysis
• Formulation characterization

This approach helps distinguish the analytical characteristics of CJC-1295 Without DAC from those of Ipamorelin.

CJC-1295 Without DAC and Ipamorelin Identification

CJC-1295 Without DAC and Ipamorelin are separate peptide entities. Therefore, research findings for one compound should not automatically be applied to the other or to the combined formulation.

It is also important to distinguish CJC-1295 Without DAC from CJC-1295 with DAC because they are different molecular forms. PubChem maintains separate records for these forms.

Important Research Information

This product is presented as a two-component peptide research formulation for laboratory and analytical applications.

However, product identity, purity, concentration, formulation, and batch characteristics can vary. Therefore, the manufacturer’s documentation and batch-specific COA should remain the primary reference for the supplied material.

This information is intended for scientific, analytical, compound-identification, and legitimate laboratory research purposes. It does not provide dosing, administration, treatment, or performance-enhancement instructions.